Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,16 USD | -1,89% | -9,76% | -20,46% |
11/03 | Sectorupdate: Aandelen gezondheidszorg eind van de middag zachter | MT |
11/03 | Sectorupdate: Gezondheidszorg | MT |
Omzet 2021 | 172 mln. 160 mln. | Omzet 2022 | 317 mln. 296 mln. | Marktkapitalisatie | 380 mln. 356 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -8 mln. -7,48 mln. | Nettowinst (verlies) 2022 | 35 mln. 32,73 mln. | EV/omzet 2021 | 3,44 x |
Nettoliquiditeiten 2021 | 67,84 mln. 63,45 mln. | Nettoschuld 2022 | 10,19 mln. 9,53 mln. | EV/omzet 2022 | 1,23 x |
K/w-verhouding 2021 |
-77
x | K/w-verhouding 2022 |
10,7
x | Werknemers | 134 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 65,14% |
Recentste transcriptie over Eagle Pharmaceuticals, Inc.
1 dag | -1,89% | ||
1 week | -9,76% | ||
Lopende maand | -20,61% | ||
1 maand | -17,46% | ||
3 maanden | -23,11% | ||
6 maanden | -69,52% | ||
Lopend jaar | -20,46% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Graves
CEO | Chief Executive Officer | 61 | 01-11-13 |
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 01-03-07 |
Ryan Debski
CMP | Compliance Officer | - | 01-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 01-03-07 |
Jennifer Simpson
BRD | Director/Board Member | 55 | 28-08-19 |
Richard Edlin
BRD | Director/Board Member | 63 | 17-03-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.54% | 29 M€ | -4,33% | ||
0.25% | 27 M€ | -5,03% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 4,16 | -1,89% | 79 708 |
25-04-24 | 4,24 | -6,81% | 130 193 |
24-04-24 | 4,55 | -4,61% | 95 218 |
23-04-24 | 4,77 | +4,84% | 88 216 |
22-04-24 | 4,55 | -1,30% | 283 208 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-20,46% | 54,03 mln. | |
+5,31% | 70,44 mld. | |
+10,97% | 8,94 mld. | |
-16,83% | 4,75 mld. | |
+43,48% | 4,5 mld. | |
+3,20% | 3,85 mld. | |
+18,82% | 2,38 mld. | |
-21,36% | 2,34 mld. | |
-29,67% | 2,2 mld. | |
+8,38% | 1,96 mld. |